AnalystsFaisal Khurshid
Faisal Khurshid's Stock Forecasts

Analyst Ranking
Bottom 13%
#4367 out of 4986 analysts
Average Return
-4.06%
Win Rate
50%9 out of 18
Risk vs Reward
Poor
Good

Faisal Khurshid's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Trevi Therapeutics IncTRVI
+134.62%$3.12$7.32
2024-09-09 -
2025-08-19
Buy
Ani Pharmaceuticals IncANIP
+52.31%$59.17$90.12
2024-12-11 -
2025-08-19
Buy
Rhythm Pharmaceuticals IncRYTM
+46.39%$66.39$97.19
2025-07-07 -
2025-08-19
Buy
Spyre Therapeutics IncSYRE
+36.53%$11.80$16.11
2025-04-08 -
2025-08-19
Buy
Atyr Pharma IncATYR
+22.96%$3.79$4.66
2025-02-18 -
2025-08-19
Buy

Faisal Khurshid Analyst Color

Get additional color on Faisal Khurshid's coverage of popular stocks

Faisal Khurshid's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Shattuck Labs IncSTTK
2Buy$2.00+94.17%Maintains
6 days ago
Rhythm Pharmaceuticals IncRYTM
2Buy$102.00+4.95%Maintains
a month ago
Abcellera Biologics IncABCL
1Buy$5.00+16.55%Assumes
a month ago
Ironwood Pharmaceuticals IncIRWD
2Hold$1.00-6.54%Maintains
4 months ago
Spyre Therapeutics IncSYRE
1Buy$45.00+179.33%Initiates Coverage On
4 months ago
Nurix Therapeutics IncNRIX
1Hold$16.00+62.60%Initiates Coverage On
5 months ago
Pliant Therapeutics IncPLRX
2Hold$2.00+36.05%Downgrades
6 months ago
Atyr Pharma IncATYR
1Buy$16.00+243.35%Initiates Coverage On
6 months ago
Kymera Therapeutics IncKYMR
2Buy$60.00+40.94%Maintains
8 months ago
Ani Pharmaceuticals IncANIP
1Buy$80.00-11.23%Initiates Coverage On
8 months ago
Zura Bio LtdZURA
1Buy$15.00+767.05%Initiates Coverage On
10 months ago
Trevi Therapeutics IncTRVI
1Buy$7.00-4.37%Assumes
a year ago
Puretech Health PLCPRTC
1Buy$45.00+142.61%Assumes
a year ago
Galapagos NvGLPG
1Hold$24.00-25.23%Initiates Coverage On
a year ago
Geron CorpGERN
1Buy$7.00+389.51%Initiates Coverage On
a year ago
Mannkind CorpMNKD
1Buy$8.00+102.02%Assumes
a year ago
Immunic IncIMUX
1Buy$5.00+447.65%Assumes
a year ago
Fusion Pharmaceuticals IncFUSN
1Hold$21.00N/ADowngrades
a year ago
Rain Oncology IncRAIN2
1Buy$11.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.